Azenta, Inc. (AZTA)
After hours:
| Previous close | 51.95 |
| Open | 51.93 |
| Bid | 52.23 x 200 |
| Ask | 52.33 x 100 |
| Day's range | 51.13 - 52.51 |
| 52-week range | 43.43 - 69.16 |
| Volume | |
| Avg. volume | 511,317 |
| Market cap | 2.818B |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.72 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Dec 2021 |
| 1y target est | 62.80 |
Simply Wall St.The past three years for Azenta (NASDAQ:AZTA) investors has not been profitable
Many investors define successful investing as beating the market average over the long term. But in any portfolio...
PR NewswireAzenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn's & Colitis Foundation (the "Foundation") as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn's disease and ulcerative colitis. Azenta will provide sample management services, including sample processing, analysis, logistics, and storage for these pivotal studies.
- PR Newswire
Azenta to Participate in the Jefferies Global Healthcare Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY, on Wednesday, June 5, 2024, which includes a presentation beginning at 11:00 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
